RASSF2 and acute myeloid leukemia: Despite this, re-expression of RASSF2 in t(8;21) AML cells did not affect canonical Ras signaling through the MAPK/ERK or AKT pathways following stimulation with cytokines (Supplementary Fig. 3d).